The U.S. Food and Drug Administration approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced CSCC.
U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing (NGS)-based test for minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL) or multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person’s bone marrow.
The U.S. Food and Drug Administration approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).
Geetanjali Institute of Pharmacy (GIP), Geetanjali University, Udaipur has celebrated the World Pharmacists Day on 25th September, 2018. This year’s theme is “Pharmacists: Your medicines experts”. GIP organized various events like literary competition (Pharma Quiz, Essay writing and Debate); cultural (Song/Dance competition, Drama); blood donation camp and other including general awareness rally to celebrate the world Pharmacist day.
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
